RAD - Rite Aid Corporation Stock Price, Fair Value and News

0.14USD0.00 (0.00%)Market Closed

Market Summary

USD0.140.00

Market Closed

0.00%

RAD Stock Price

View Fullscreen

RAD RSI Chart

RAD Valuation

Market Cap

7.9M

Price/Earnings (Trailing)

Price/Sales (Trailing)

3e-4

EV/EBITDA

0.08

Price/Free Cashflow

-0.01

RAD Price/Sales (Trailing)

RAD Profitability

Operating Margin

20.14%

EBT Margin

-7.04%

Return on Equity

-27.62%

Return on Assets

-22.95%

Free Cashflow Yield

-7.4K%

RAD Fundamentals

RAD Revenue

Revenue (TTM)

23.5B

Rev. Growth (Yr)

-4.32%

Rev. Growth (Qtr)

-0.13%

RAD Earnings

Earnings (TTM)

-1.6B

Earnings Growth (Yr)

-207.9%

Earnings Growth (Qtr)

-232.56%

Breaking Down RAD Revenue

Last 90 days

-74.1%

Trailing 12 Months

-95.8%

How does RAD drawdown profile look like?

RAD Financial Health

Current Ratio

0.57

Debt/Equity

0.56

Debt/Cashflow

-0.12

RAD Investor Care

Shares Dilution (1Y)

0.01%

Diluted EPS (TTM)

-29.62

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	24.1B	23.7B	23.5B	0
2022	24.6B	24.4B	24.2B	24.1B
2021	24.0B	24.2B	24.3B	24.4B
2020	21.9B	22.6B	23.2B	23.9B
2019	21.6B	21.6B	21.6B	21.6B
2018	21.5B	21.5B	21.6B	21.7B
2017	22.9B	22.6B	22.4B	22.0B
2016	18.3B	22.3B	22.8B	22.8B
2015	26.5B	24.2B	17.9B	16.7B
2014	25.5B	25.7B	25.9B	26.3B
2013	25.4B	25.2B	25.3B	25.4B
2012	26.1B	26.2B	26.2B	26.1B
2011	25.2B	25.2B	25.3B	25.4B
2010	25.7B	25.5B	25.4B	25.2B
2009	26.3B	0	26.1B	25.9B

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Rite Aid Corporation

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jul 27, 2023	kazmaier jessica	sold (taxes)	-10,955	1.58	-6,934	evp, chief hr officer
Jul 27, 2023	schroeder matt	sold (taxes)	-27,411	1.58	-17,349	evp, chief financial officer
Jul 27, 2023	mennen justin l.	sold (taxes)	-7,849	1.58	-4,968	evp, chief information officer
Jul 07, 2023	schroeder matt	sold (taxes)	-23,327	1.64	-14,224	evp, chief financial officer
Jul 07, 2023	bixler steven	sold (taxes)	-582	1.64	-355	chief accounting officer
Jul 07, 2023	mennen justin l.	sold (taxes)	-6,851	1.64	-4,178	evp, chief information officer
Jul 07, 2023	kazmaier jessica	sold (taxes)	-8,591	1.64	-5,239	evp, chief hr officer
Apr 25, 2023	mennen justin l.	acquired	-	-	5,547	evp, chief information officer
Apr 25, 2023	kazmaier jessica	acquired	-	-	5,953	evp, chief hr officer
Apr 25, 2023	schroeder matt	acquired	-	-	11,416	evp, chief financial officer

Which funds bought or sold RAD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 19, 2024	CALDWELL SUTTER CAPITAL, INC.	unchanged	-	-1.00	1.00	-%
Apr 18, 2024	LifeGuide Financial Advisors, LLC	sold off	-100	-2,189	-	-%
Apr 17, 2024	Trivant Custom Portfolio Group, LLC	unchanged	-	-15.00	40.00	-%
Apr 15, 2024	GoalVest Advisory LLC	new	-	1.00	1.00	-%
Apr 08, 2024	TOMPKINS FINANCIAL CORP	sold off	-100	-18.00	-	-%
Apr 02, 2024	ST GERMAIN D J CO INC	unchanged	-	-1.00	4.00	-%
Mar 28, 2024	Newbridge Financial Services Group, Inc.	sold off	-100	-941	-	-%
Mar 22, 2024	PNC Financial Services Group, Inc.	sold off	-100	-4,838	-	-%
Mar 11, 2024	VANGUARD GROUP INC	sold off	-100	-1,297,280	-	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	sold off	-100	-18,837	-	-%

Are Funds Buying or Selling RAD?

Are funds buying RAD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own RAD

No. of Funds

Unveiling Rite Aid Corporation's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Jul 07, 2023	blackrock inc.	2.0%	1,155,401	SC 13G/A
Feb 09, 2023	vanguard group inc	4.89%	2,765,172	SC 13G/A
Feb 01, 2023	blackrock inc.	6.7%	3,795,009	SC 13G/A
Jul 11, 2022	vanguard group inc	6.82%	3,794,891	SC 13G/A
Mar 09, 2022	vanguard group inc	11.88%	6,624,983	SC 13G/A
Feb 10, 2022	vanguard group inc	9.49%	5,291,657	SC 13G/A
Feb 01, 2022	blackrock inc.	8.4%	4,660,384	SC 13G/A
Jan 31, 2022	invesco ltd.	4.9%	2,726,826	SC 13G/A
Feb 16, 2021	invesco ltd.	5.0%	2,780,873	SC 13G
Feb 10, 2021	vanguard group inc	9.04%	4,991,730	SC 13G/A

Recent SEC filings of Rite Aid Corporation

View All Filings

Date Filed	Form Type	Document
Feb 06, 2024	8-K	Current Report

Peers (Alternatives to Rite Aid Corporation)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	357.8B	85.2B	-4.29%	-10.06%	10.18	4.2	6.46%	95.94%
MRK	321.7B	60.1B	1.36%	9.00%	881.36	5.35	1.40%	-97.49%
PFE	148.3B	46.5B	-4.27%	-33.23%	-106.79	3.19	42.59%	-114.62%
AMGN	146.3B	28.2B	-2.78%	11.49%	21.78	5.19	7.09%	2.52%
GILD	83.6B	27.1B	-7.58%	-21.63%	14.75	3.08	-0.60%	23.36%
TEVA	14.6B	15.8B	-7.47%	58.08%	-25.3	0.92	6.17%	76.47%
MID-CAP
PRGO	4.2B	4.7B	0.71%	-13.71%	-333.24	0.91	4.58%	90.97%
ALKS	4.1B	1.7B	-9.74%	-19.21%	11.58	2.48	49.61%	324.78%
BHC	3.1B	8.8B	-9.70%	20.22%	-5.28	0.36	7.79%	-163.11%
AMPH	2.0B	644.4M	-6.03%	4.38%	14.34	3.06	29.14%	50.51%
SMALL-CAP
TLRY	1.4B	743.2M	-14.42%	-17.86%	-4.05	1.92	24.65%	80.36%
TXMD	22.3M	1.3M	-15.72%	-46.54%	-2.17	17.09	-98.14%	-109.18%
ACRX	16.3M	-	-17.24%	40.47%	-0.89	0.22	2882.68%	-138.52%
AGRX	2.7M	19.6M	-33.33%	-94.15%	-0.19	0.14	80.00%	43.08%
ACOR	645.9K	117.6M	-96.48%	-95.45%	0	0.01	-0.79%	-283.60%

Rite Aid Corporation News

Latest updates

Rite Aid Corporation Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	-0.1%	5,646,081,000	5,653,162,000	6,092,901,500	6,083,346,000	5,901,069,000	6,014,583,000	6,065,390,000	6,228,880,000	6,113,000,000	6,160,985,000	5,916,856,000	6,117,038,000	5,981,970,000	6,027,376,000	5,727,242,000	5,462,298,000	5,366,264,000	5,372,589,000	5,379,645,000	5,450,060,000	5,421,362,000
Cost Of Revenue	1.7%	4,550,485,000	4,474,636,000	4,843,937,500	4,879,594,000	4,746,574,000	4,817,854,000	4,824,077,000	4,894,497,000	4,867,076,000	4,876,110,000	4,774,297,000	4,913,939,000	4,821,625,000	4,829,057,000	4,460,621,000	4,273,323,000	4,221,825,000	4,245,866,000	4,215,281,000	4,267,972,000	4,260,211,000
Costs and Expenses	11.8%	6,663,773,000	5,958,387,000	6,355,633,500	6,151,000,000	6,220,392,000	6,121,277,000	6,461,147,000	6,266,113,000	6,209,991,000	6,173,262,000	5,947,974,000	6,112,277,000	5,995,120,000	6,108,096,000	5,718,974,000	5,409,136,000	5,417,341,000	5,464,554,000	5,440,270,000	5,468,781,000	5,880,269,000
S&GA Expenses	16.2%	1,458,466,000	1,255,223,000	1,296,059,000	1,194,546,000	1,193,553,000	1,217,929,000	1,243,841,000	1,276,920,000	1,267,753,000	1,245,362,000	1,187,541,000	1,156,355,000	1,116,142,000	1,197,147,000	1,154,300,000	1,134,854,000	1,135,530,000	1,162,652,000	1,143,202,000	1,142,555,000	1,153,991,000
EBITDA Margin	-156.4%	-0.05	-0.02	-0.01	-0.02	-0.02	-0.01	0.00	0.01	0.02	0.02	0.02	0.02	-	-	-	-	-	-	-	-	-
Interest Expenses	11.4%	72,658,000	65,220,000	66,331,000	57,416,000	52,533,000	48,119,000	46,094,000	47,794,000	48,592,000	49,121,000	49,999,000	50,835,000	50,007,000	50,547,000	53,429,000	57,856,000	60,102,000	58,270,000	52,695,000	56,008,000	56,233,000
Income Taxes	56.6%	2,338,000	1,493,000	-21,421,000	-510,000	11,967,000	3,497,000	-6,695,000	-1,175,000	3,310,000	780,000	-12,623,000	437,000	47,000	-8,018,000	351,729,000	876,000	27,628,000	7,374,000	195,004,000	-1,471,000	-106,559,000
Earnings Before Taxes	-233.4%	-1,017,692,000	-305,225,000	-262,732,000	-67,654,000	-319,323,000	-106,694,000	-395,757,000	-37,233,000	-96,991,000	-12,277,000	-31,118,000	4,761,000	-13,150,000	-80,720,000	8,268,000	53,162,000	-51,077,000	-91,965,000	-60,625,000	-18,721,000	-458,907,000
EBT Margin	-75.0%	-0.07	-0.04	-0.03	-0.04	-0.04	-0.03	-0.02	-0.01	-0.01	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-
Net Income	-232.6%	-1,020,030,000	-306,718,000	-241,311,000	-67,144,000	-331,290,000	-110,191,000	-389,062,000	-36,058,000	-100,301,000	-13,057,000	-18,495,000	4,324,000	-13,197,000	-63,541,000	-324,721,000	51,485,000	-79,279,000	-99,659,000	-272,979,000	-4,510,000	-359,140,000
Net Income Margin	-74.6%	-0.07	-0.04	-0.03	-0.04	-0.04	-0.03	-0.02	-0.01	-0.01	0.00	0.00	-0.02	-	-	-	-	-	-	-	-	-
Free Cashflow	-17.9%	-481,601,000	-408,429,000	223,691,000	82,289,000	-248,291,000	-325,413,000	293,623,000	-42,683,000	-20,469,000	-45,289,000	291,270,000	158,445,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-6.9%	7,126	7,650	7,527	8,210	8,367	8,550	8,529	9,499	9,364	9,351	9,335	9,429	9,620	9,521	9,452	10,429	10,673	10,530	7,591	8,083	8,166
Current Assets	2.4%	3,739	3,649	3,301	3,678	3,741	3,569	3,449	4,056	3,833	3,685	3,595	3,951	4,066	3,879	3,701	4,216	4,385	4,129	4,102	4,330	4,372
Cash Equivalents	-31.4%	93.00	136	157	103	47.00	56.00	40.00	155	147	118	161	51.00	93.00	288	218	289	142	190	144	410	132
Inventory	2.2%	1,994	1,950	1,901	1,981	2,026	1,975	1,959	1,950	1,892	1,857	1,865	1,971	1,938	1,890	1,922	1,957	1,969	1,876	1,872	1,894	1,848
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,180	1,216	1,254	1,270	1,285	1,309	1,336	1,351
Goodwill	-74.6%	90.00	356	508	627	627	879	879	1,108	1,108	1,108	1,108	1,108	1,108	1,108	1,108	1,108	1,108	1,108	1,108	1,108	1,108
Liabilities	5.7%	9,092	8,598	8,169	8,614	8,704	8,558	8,430	9,027	8,858	8,747	8,720	8,819	9,017	8,907	8,778	9,413	9,713	9,494	6,405	6,630	6,710
Current Liabilities	135.1%	6,518	2,773	2,728	2,824	2,819	2,828	2,933	2,949	2,791	2,739	2,603	2,656	2,581	2,638	2,766	2,887	2,860	2,845	2,443	2,720	2,692
Long Term Debt	-100.0%	-	3,328	2,925	3,189	3,223	3,026	2,733	3,167	3,114	3,015	3,063	3,201	3,507	3,322	3,077	3,566	3,835	3,582	3,455	3,394	3,482
LT Debt, Non Current	-100.0%	-	3,328	2,925	3,189	3,223	3,026	2,733	3,167	3,114	3,015	3,063	3,201	3,507	3,322	3,077	3,566	3,835	3,582	3,455	3,394	3,482
Shareholder's Equity	-	-	-	-	-	-	-	99.00	472	505	604	615	611	603	614	675	1,016	961	1,035	1,187	1,453	1,456
Retained Earnings	-14.8%	-7,928	-6,908	-6,601	-6,360	-6,293	-5,961	-5,851	-5,462	-5,426	-5,326	-5,313	-5,294	-5,298	-5,285	-5,222	-4,897	-4,948	-4,869	-4,713	-4,440	-4,435
Additional Paid-In Capital	0.0%	5,920	5,919	5,918	5,915	5,916	5,913	5,910	5,902	5,900	5,899	5,897	5,896	5,894	5,893	5,891	5,889	5,886	5,882	5,877	4,860	4,859
Shares Outstanding	-0.4%	56.00	57.00	57.00	57.00	57.00	56.00	56.00	56.00	56.00	55.00	55.00	55.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	448	-	-	-	925	-	-	-	738	-	-	-	349	-	-	-	1,449

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	-18.3%	-440,623	-372,538	266,413	132,609	-199,224	-252,237	342,712	-3,038	25,723	13,875	359,022	222,749	-358,322	-118,270	417,182	423,713	-278,799	-51,239	-215,928	351,121	-284,588
Share Based Compensation	-1.2%	1,068	1,081	2,902	566	4,735	3,334	4,230	217	5,792	2,811	4,326	2,867	3,936	1,874	2,489	3,506	4,712	5,380	552	1,317	5,215
Cashflow From Investing	53.8%	-18,161	-39,346	-14,183	-39,966	3,975	-54,585	-22,830	-20,705	-35,842	-54,696	-63,841	13,292	-22,367	-36,419	-43,250	-11,254	-46,812	-48,533	-46,149	-57,635	-45,645
Cashflow From Financing	6.6%	416,183	390,260	-198,133	-36,397	185,997	323,161	-435,450	32,468	38,203	-1,601	-185,092	-277,958	185,103	212,704	-467,795	-283,817	265,734	159,226	11,988	-91,897	1,122,324

RAD Income Statement

2023-09-02

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 02, 2023	Aug. 27, 2022	Sep. 02, 2023	Aug. 27, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenues	$ 5,646,081	$ 5,901,069	$ 11,299,243	$ 11,915,652
Costs and expenses:
Cost of revenues	4,550,485	4,746,574	9,025,121	9,564,428
Selling, general and administrative expenses	1,458,466	1,193,553	2,713,689	2,411,482
Facility exit and impairment charges	310,761	45,845	330,762	112,416
Goodwill and intangible asset impairment charges	295,490	252,200	446,990	252,200
Interest expense	72,658	52,533	137,878	100,652
Gain on debt modifications and retirements, net		(41,312)		(41,312)
Gain on sale of assets, net	(24,087)	(29,001)	(32,280)	(58,197)
Total costs and expenses	6,663,773	6,220,392	12,622,160	12,341,669
Loss before income taxes	(1,017,692)	(319,323)	(1,322,917)	(426,017)
Income tax expense	2,338	11,967	3,831	15,464
Net loss	(1,020,030)	(331,290)	(1,326,748)	(441,481)
Computation of loss attributable to common stockholders:
Net loss attributable to common stockholders - basic	(1,020,030)	(331,290)	(1,326,748)	(441,481)
Net loss attributable to common stockholders - diluted	$ (1,020,030)	$ (331,290)	$ (1,326,748)	$ (441,481)
Basic loss per share:
Basic loss per share	$ (18.44)	$ (6.07)	$ (24.02)	$ (8.11)
Diluted loss per share:
Diluted loss per share	$ (18.44)	$ (6.07)	$ (24.02)	$ (8.11)

RAD Balance Sheet

2023-09-02

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 02, 2023	Mar. 04, 2023
Current assets:
Cash and cash equivalents	$ 92,926	$ 157,151
Accounts receivable, net	1,472,755	1,149,958
Inventories, net of LIFO reserve of $554,932 and $539,932	1,993,873	1,900,744
Prepaid expenses and other current assets	179,099	93,194
Total current assets	3,738,653	3,301,047
Property, plant and equipment, net	790,001	907,771
Operating lease right-of-use assets	2,239,043	2,497,206
Goodwill	90,436	507,936
Other intangibles, net	201,572	250,112
Deferred tax assets	12,368	12,368
Other assets	53,879	50,922
Total assets	7,125,952	7,527,362
Current liabilities:
Current maturities of long-term debt and lease financing obligations	3,773,356	6,332
Accounts payable	1,428,286	1,494,611
Accrued salaries, wages and other current liabilities	894,079	724,529
Current portion of operating lease liabilities	422,233	502,403
Total current liabilities	6,517,954	2,727,875
Long-term debt, less current maturities		2,925,258
Long-term operating lease liabilities	2,373,953	2,372,943
Lease financing obligations, less current maturities	11,718	12,580
Other noncurrent liabilities	188,597	130,482
Total liabilities	9,092,222	8,169,138
Commitments and contingencies
Stockholders' deficit:
Common stock, par value $1 per share; 75,000 shares authorized; shares issued and outstanding 56,486 and 56,629	56,486	56,629
Additional paid-in capital	5,920,361	5,917,964
Accumulated deficit	(7,928,265)	(6,601,517)
Accumulated other comprehensive loss	(14,852)	(14,852)
Total stockholders' deficit	(1,966,270)	(641,776)
Total liabilities and stockholders' deficit	$ 7,125,952	$ 7,527,362

About Rite Aid Corporation

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

CEO	Ms. Elizabeth H. Burr
WEBSITE	riteaid.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	47000

Rite Aid Corporation Frequently Asked Questions

What is the ticker symbol for Rite Aid Corporation? What does RAD stand for in stocks?

RAD is the stock ticker symbol of Rite Aid Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Rite Aid Corporation (RAD)?

As of Mon Jan 08 2024, market cap of Rite Aid Corporation is 7.92 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of RAD stock?

You can check RAD's fair value in chart for subscribers.

What is the fair value of RAD stock?

You can check RAD's fair value in chart for subscribers. The fair value of Rite Aid Corporation is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Rite Aid Corporation is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for RAD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Rite Aid Corporation a good stock to buy?

The fair value guage provides a quick view whether RAD is over valued or under valued. Whether Rite Aid Corporation is cheap or expensive depends on the assumptions which impact Rite Aid Corporation's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RAD.

What is Rite Aid Corporation's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Jan 08 2024, RAD's PE ratio (Price to Earnings) is 0 and Price to Sales (PS) ratio is 0. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RAD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Rite Aid Corporation's stock?

In the past 10 years, Rite Aid Corporation has provided -0.482 (multiply by 100 for percentage) rate of return.